Meeting News
August 11, 2017
CHICAGO – Thoracic radiation used in combination with chemotherapy may improve survival outcomes compared with chemotherapy alone in patients…
Meeting NewsVideo
August 10, 2017
CHICAGO — Lecia V. Sequist, MD, MPH, the Mary B. Saltonstall Endowed Chair in Oncology at Massachusetts General Hospital and…
Meeting News
August 10, 2017
In this guest commentary,
Leonard J. Appleman, MD, PhD,
of the division of hematology/oncology at the University of Pittsburgh…
Meeting News
August 8, 2017
CHICAGO – Retreatment with cabazitaxel demonstrated encouraging activity and acceptable toxicity when used in combination with a new hormonal…
Meeting News
August 7, 2017
CHICAGO – Reducing the duration of androgen deprivation therapy from 36 to 18 months improved quality of life without affecting survival…
Meeting News
August 6, 2017
CHICAGO — Palbociclib failed to reach a pre-specified response rate in patients with stage IV squamous cell lung cancer, according to results…
Meeting News
August 3, 2017
CHICAGO — First-line therapy with ado-trastuzumab emtansine improved OS and reduced grade 3 and higher adverse events in patients with…
Meeting News
August 2, 2017
CHICAGO — Durvalumab demonstrated an encouraging clinical response and a positive safety profile in patients with locally advanced or…
Meeting News
August 1, 2017
CHICAGO — Age does not appear to impact the efficacy of cabozantinib for the treatment of advanced renal cell carcinoma, according to a…
Meeting NewsVideo
July 31, 2017
CHICAGO – The addition of pembrolizumab to standard chemotherapy improved the pathologic complete response rate among women with…